Lebanon National Drugs Database
This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
You can search in the form below for information related to drugs including Subsidy percentage
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| L01CD01 | PACLITAXEL NEAPOLIS | G | Paclitaxel - 30mg | 30mg | Injectable concentrate for solution | 3514148.1375 |
| L01CD01 | PANATAXEL | G | Paclitaxel - 30mg/5ml | 30mg/5ml | Injectable concentrated solution | 3563870.31 |
| L01CD01 | PATAXEL | G | Paclitaxel - 30mg/5ml | 30mg/5ml | Injectable concentrate for solution | 2447137.1925 |
| L01CD01 | PACLITAXEL MYLAN PHARMA 6MG/ML | G | Paclitaxel - 100mg/16.7ml | 100mg/16.7ml | Injectable concentrated powder for solution | 22410062.068918 |
| L01CD01 | PANATAXEL | G | Paclitaxel - 100mg/16.7ml | 100mg/16.7ml | Injectable concentrated solution | 7071670.2483 |
| L01CD01 | PATAXEL | G | Paclitaxel - 100mg/16.7ml | 100mg/16.7ml | Injectable concentrate for solution | 8500053.97395 |
| L01CD01 | EBETAXEL | G | Paclitaxel - 150mg/25ml | 150mg/25ml | Injectable concentrated solution | 15457059.1224 |
| L01CD01 | PACLITAXEL NEAPOLIS | G | Paclitaxel - 150mg/25ml | 150mg/25ml | Injectable concentrate for solution | 15665972.3136 |
| L01CD01 | PANATAXEL | G | Paclitaxel - 150mg/25ml | 150mg/25ml | Injectable concentrated solution | 16521761.2896 |
| L01CD01 | ABRAXANE | BioTech | Paclitaxel Albumin- bound - 5mg/ml | 5mg/ml | Injectable powder for dispersion | 17850751.2288 |
| L01CB01 | ETOPOSIDE EBEWE | G | Etoposide - 100mg/5ml | 100mg/5ml | Injectable concentrated solution | 768677.91 |
| L01CB01 | ETOPOSIDE VIATRIS 20MG/ML | G | Etoposide - 100mg/5ml | 100mg/5ml | Injectable concentrated solution | 1544465.811889 |
| L01CB01 | ETOPOSIDE VIATRIS 20MG/ML | G | Etoposide - 100mg/5ml | 100mg/5ml | Injectable concentrated solution | |
| L01CA04 | EBERELBIN | G | Vinorelbine (tartrate) - 50mg/5ml | 50mg/5ml | Injectable concentrated solution | 6834782.955 |
| L01CA04 | NAVELBINE | B | Vinorelbine (ditartrate) - 20mg | 20mg | Capsule, soft gelatin | 4048997.4525 |
| L01CA04 | NAVELBINE | B | Vinorelbine (ditartrate) - 30mg | 30mg | Capsule, soft gelatin | 6072824.2575 |
Download the new version of the MOPH app
for the latest updates on Coronavirus.
The new version of the MOPH APP will provide you with all the reliable information on COVID-19 with ongoing update of the confirmed cases and data. If you are showing any symptoms, the “Symptoms Checker” will be your self-help guide to assess them.
